» Articles » PMID: 2555138

Tumor Necrosis Factor and Interleukin-1 Are Potent Inhibitors of Angiotensin-II-induced Aldosterone Synthesis

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1989 Dec 1
PMID 2555138
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1), mediate many inflammatory and cellular responses. However, the effects of TNF and IL-1 on basal and angiotensin-II (AII)-stimulated aldosterone synthesis are not known. We studied the effect of recombinant and purified TNF and IL-1 on basal as well as AII-, ACTH-, and K+-induced aldosterone synthesis in isolated rat adrenal glomerulosa cells. Since we have previously shown that AII action is mediated by activation of the 12-lipoxygenase (12LO) pathway of arachidonic acid, we also evaluated the effects of these cytokines on the 12LO product 12-hydroxyeicosatetraenoic acid (12HETE) using a validated RIA technique. TNF at 2.5 and 5.0 ng/ml produced a dose-dependent inhibition of AII-induced aldosterone synthesis [AII, 39.0 +/- 3.3 ng/10(6) cells.h; AII plus TNF (5.0 ng/ml), 14.3 +/- 1.6; P less than 0.001 vs. AII; AII plus TNF (2.5 ng/ml), 24.7 +/- 3.2; P less than 0.01 vs. AII]. Similarly, TNF at 5.0 ng/ml also attenuated the stimulatory effect of ACTH (10(-9) M). However, K+-induced aldosterone synthesis was not altered. TNF also did not alter basal aldosterone levels. AII, as previously shown, stimulates 12HETE synthesis (basal, 608 +/- 114 pg/10(5) cells.h; versus AII, 1268 +/- 197; P less than 0.02). TNF at concentrations of 1.0-5.0 ng/ml produced a dose-dependent inhibition of AII stimulatory action on 12HETE synthesis [AII plus TNF (1.0 ng/ml), 650 +/- 26 pg, P less than 0.03 vs. AII; AII plus TNF (5.0 ng/ml), 390 +/- 46; P less than 0.01 vs. AII plus TNF (1.0 ng/ml)]. In addition, 12HETE at 10(-8) M completely restored the effects of AII during blockage by TNF. Purified human IL-1 (75% beta, 25% alpha) as well as recombinant human IL-1 beta at concentrations as low as 50 pg/ml inhibited AII-induced aldosterone synthesis. IL-1 beta did not alter ACTH- or K+-induced aldosterone synthesis and, in fact, had a tendency to potentiate ACTH effects. These results suggest that the cytokines TNF and IL-1 are potent inhibitors, particularly of AII action in the adrenal glomerulosa cell. Therefore, local or systemically produced TNF or IL-1 may be important negative modulators of aldosterone synthesis.

Citing Articles

Critical Illness-Related Corticosteroid Insufficiency (CIRCI) Among Patients with COVID-19 at a Tertiary Hospital: Clinical Characteristics and Outcomes.

Arcellana A, Lim K, Arcegono M, Jimeno C J ASEAN Fed Endocr Soc. 2023; 38(1):90-99.

PMID: 37252409 PMC: 10213165. DOI: 10.15605/jafes.038.01.02.


A case of adrenal insufficiency during multisystem inflammatory syndrome in children.

Kilci F, Yetimakman A, Jones J, Cizmecioglu F Clin Pediatr Endocrinol. 2022; 31(3):163-167.

PMID: 35928381 PMC: 9297178. DOI: 10.1297/cpe.2022-0011.


The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel.

Jensterle M, Herman R, Janez A, Al Mahmeed W, Al-Rasadi K, Al-Alawi K Int J Mol Sci. 2022; 23(13).

PMID: 35806331 PMC: 9266848. DOI: 10.3390/ijms23137326.


Unmasking of Addison's disease in COVID-19.

Bhattarai P, Allen H, Aggarwal A, Madden D, Dalton K SAGE Open Med Case Rep. 2022; 9:2050313X211027758.

PMID: 35154776 PMC: 8826098. DOI: 10.1177/2050313X211027758.


Adrenal Insufficiency in Coronavirus Disease 2019 (COVID-19)-Infected Patients without Preexisting Adrenal Diseases: A Systematic Literature Review.

Vakhshoori M, Heidarpour M, Bondariyan N, Sadeghpour N, Mousavi Z Int J Endocrinol. 2021; 2021:2271514.

PMID: 34539780 PMC: 8443384. DOI: 10.1155/2021/2271514.